Even if the patient had similar clinical features (age, Lynch-syndrome, and multiple HNPCC-associated cancer entities) and a lower tumor burden (liver metastases only) compared to our patient, only a partial metabolic response and stabilized but strongly elevated CEA levels were reached [49]. This evidence concerns the gene CEACAM5 and cancer.